|
AU2012202475A1
|
|
Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators
|
|
AU2011250836A1
|
|
Total synthesis of salinosporamide a and analogs thereof
|
|
CN102089312A
|
|
Salinosporamide derivatives as proteasome inhibitors
|
|
US2009285836A1
|
|
Use of salinosporamide a to inhibit metastasis
|
|
AU2009241635A1
|
|
Total synthesis of Salinosporamide A and analogs thereof
|
|
US2008280968A1
|
|
Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
|
|
WO2008124699A1
|
|
A method of using proteasome inhibitors in combination with histone deacetylase inhibitors to treat cancer
|
|
US2008188544A1
|
|
Lyophilized formulations of Salinosporamide A
|
|
WO2007130404A1
|
|
Methods of using [3.2.0] heterocyclic compounds and analogs thereof for the treatment of lung cancer
|
|
WO2007120801A2
|
|
Fermentation method
|
|
NZ572026A
|
|
Total synthesis of salinosporamide a and analogs thereof
|
|
CA2628110A1
|
|
Methods of sensitizing cancer to therapy-induced cytotoxicity
|
|
US2007078138A1
|
|
Analogs of dehydrophenylahistins and their therapeutic use
|
|
EP1926724A1
|
|
Analogs of dehydrophenylahistins and their therapeutic use
|
|
US2009197310A1
|
|
Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogs
|
|
BRPI0615976A2
|
|
modulators of interleukin-1 and tumor necrosis factor-a; syntheses of such modulators and methods for using such modulators
|
|
KR20080035650A
|
|
Interleukin-1 and tumor necrosis factor-a modulators, syntheses of such modulators and methods of using such modulators
|
|
CN101365674A
|
|
Interleukin-1 and tumor necrosis factor-a modulators, syntheses of such modulators and methods of using such modulators
|
|
US2007004676A1
|
|
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
|
|
US2006235226A1
|
|
Synthesis of diketopiperazines
|
